146 related articles for article (PubMed ID: 10891119)
1. Poly(N-acryl amino acids): a new class of biologically active polyanions.
Bentolila A; Vlodavsky I; Ishai-Michaeli R; Kovalchuk O; Haloun C; Domb AJ
J Med Chem; 2000 Jun; 43(13):2591-600. PubMed ID: 10891119
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of heparin-mimicking compounds in induction of bFGF release from extracellular matrix and inhibition of smooth muscle cell proliferation and heparanase activity.
Benezra M; Ishai-Michaeli R; Ben-Sasson SA; Vlodavsky I
J Cell Physiol; 2002 Sep; 192(3):276-85. PubMed ID: 12124773
[TBL] [Abstract][Full Text] [Related]
3. Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activity.
Miao HQ; Ishai-Michaeli R; Peretz T; Vlodavsky I
J Cell Physiol; 1995 Sep; 164(3):482-90. PubMed ID: 7650058
[TBL] [Abstract][Full Text] [Related]
4. Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix.
Ishai-Michaeli R; Eldor A; Vlodavsky I
Cell Regul; 1990 Oct; 1(11):833-42. PubMed ID: 2088528
[TBL] [Abstract][Full Text] [Related]
5. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and properties of optically active nanostructured polymers bearing amino acid moieties by direct polycondensation of 4,4'-thiobis(2-tert-butyl-5-methylphenol) with chiral diacids.
Mallakpour S; Soltanian S
Amino Acids; 2012 Jun; 42(6):2187-94. PubMed ID: 21691754
[TBL] [Abstract][Full Text] [Related]
7. Structure and biological activity of heparinoid.
Kumar N; Bentolila A; Domb AJ
Mini Rev Med Chem; 2005 May; 5(5):441-7. PubMed ID: 15892686
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of tumor metastasis by heparanase inhibiting species of heparin.
Vlodavsky I; Mohsen M; Lider O; Svahn CM; Ekre HP; Vigoda M; Ishai-Michaeli R; Peretz T
Invasion Metastasis; 1994-1995; 14(1-6):290-302. PubMed ID: 7657522
[TBL] [Abstract][Full Text] [Related]
9. Endogenous basic fibroblast growth factor displaced by heparin from the lumenal surface of human blood vessels is preferentially sequestered by injured regions of the vessel wall.
Medalion B; Merin G; Aingorn H; Miao HQ; Nagler A; Elami A; Ishai-Michaeli R; Vlodavsky I
Circulation; 1997 Apr; 95(7):1853-62. PubMed ID: 9107173
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative capacity of synthetic dextrans on smooth muscle cell growth: the model of derivatized dextrans as heparin-like polymers.
Letourneur D; Logeart D; Avramoglou T; Jozefonvicz J
J Biomater Sci Polym Ed; 1993; 4(5):431-44. PubMed ID: 7694645
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of vascular smooth muscle cell proliferation by a novel fibroblast growth factor receptor antagonist.
Segev A; Aviezer D; Safran M; Gross Z; Yayon A
Cardiovasc Res; 2002 Jan; 53(1):232-41. PubMed ID: 11744033
[TBL] [Abstract][Full Text] [Related]
12. Exogenous leukocyte and endogenous elastases can mediate mitogenic activity in pulmonary artery smooth muscle cells by release of extracellular-matrix bound basic fibroblast growth factor.
Thompson K; Rabinovitch M
J Cell Physiol; 1996 Mar; 166(3):495-505. PubMed ID: 8600153
[TBL] [Abstract][Full Text] [Related]
13. Oligomannurarate sulfate, a novel heparanase inhibitor simultaneously targeting basic fibroblast growth factor, combats tumor angiogenesis and metastasis.
Zhao H; Liu H; Chen Y; Xin X; Li J; Hou Y; Zhang Z; Zhang X; Xie C; Geng M; Ding J
Cancer Res; 2006 Sep; 66(17):8779-87. PubMed ID: 16951194
[TBL] [Abstract][Full Text] [Related]
14. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules.
Bashkin P; Doctrow S; Klagsbrun M; Svahn CM; Folkman J; Vlodavsky I
Biochemistry; 1989 Feb; 28(4):1737-43. PubMed ID: 2541764
[TBL] [Abstract][Full Text] [Related]
15. The cysteine-free fibroblast growth factor 1 mutant induces heparin-independent proliferation of endothelial cells and smooth muscle cells.
Xue L; Shireman PK; Hampton B; Burgess WH; Greisler HP
J Surg Res; 2000 Aug; 92(2):255-60. PubMed ID: 10896831
[TBL] [Abstract][Full Text] [Related]
16. Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties.
Lapierre F; Holme K; Lam L; Tressler RJ; Storm N; Wee J; Stack RJ; Castellot J; Tyrrell DJ
Glycobiology; 1996 Apr; 6(3):355-66. PubMed ID: 8724143
[TBL] [Abstract][Full Text] [Related]
17. Importance of size and sulfation of heparin in release of basic fibroblast growth factor from the vascular endothelium and extracellular matrix.
Ishai-Michaeli R; Svahn CM; Weber M; Chajek-Shaul T; Korner G; Ekre HP; Vlodavsky I
Biochemistry; 1992 Feb; 31(7):2080-8. PubMed ID: 1536850
[TBL] [Abstract][Full Text] [Related]
18. Heparin-like synthetic polymers, named RGTAs, mimic biological effects of heparin in vitro.
Rouet V; Meddahi-Pellé A; Miao HQ; Vlodavsky I; Caruelle JP; Barritault D
J Biomed Mater Res A; 2006 Sep; 78(4):792-7. PubMed ID: 16741978
[TBL] [Abstract][Full Text] [Related]
19. Conjugates of insulin with copolymers of N-(2-hydroxypropyl) methacrylamide: effects on smooth muscle cell proliferation.
Chytry V; Letourneur D; Baudys M; Jozefonvicz J
J Biomed Mater Res; 1996 Jun; 31(2):265-72. PubMed ID: 8731216
[TBL] [Abstract][Full Text] [Related]
20. A synthetic heparin-mimicking polyanionic compound binds to the LDL receptor-related protein and inhibits vascular smooth muscle cell proliferation.
Benezra M; Vogel T; Ben-Sasson SA; Panet A; Sehayek E; Al-Haideiri M; Decklbaum RJ; Vlodavsky I
J Cell Biochem; 2001; 81(1):114-27. PubMed ID: 11180402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
